IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker
Authors:
Open Access
- 7 September 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (42) , 68140-68150
Abstract
IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarkerKeywords
This publication has 37 references indexed in Scilit:
- Preliminary assessment of nasopharyngeal carcinoma incidence in the Philippines: a second look at published data from four centersChinese Journal of Cancer, 2014
- Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian CancerPLOS ONE, 2013
- Primary Treatment Results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, IndonesiaPLOS ONE, 2013
- The role of insulin receptors and IGF-I receptors in cancer and other diseasesArchives of Physiology and Biochemistry, 2008
- PTHrP‐induced MCP‐1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitroInternational Journal of Cancer, 2007
- CCR2 expression correlates with prostate cancer progressionJournal of Cellular Biochemistry, 2007
- Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasionThe Prostate, 2006
- The Insulin‐Like Growth Factor SystemJournal of Diabetes Research, 2003
- Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cellsOncogene, 2000
- Mitogenic and Antiapoptotic Effects of Insulin-like Growth Factor Binding Protein-6 in the Human Osteoblastic Osteosarcoma Cell Line Saos-2/B-10Biochemical and Biophysical Research Communications, 1999